AAAAAA

   
Results: 1-18 |
Results: 18
UREA KINETICS AND DIALYSIS TREATMENT TIME PREDICT VANCOMYCIN ELIMINATION DURING HIGH-FLUX HEMODIALYSIS
Authors: SCHAEDELI F UEHLINGER DE
Citation: F. Schaedeli et De. Uehlinger, UREA KINETICS AND DIALYSIS TREATMENT TIME PREDICT VANCOMYCIN ELIMINATION DURING HIGH-FLUX HEMODIALYSIS, Clinical pharmacology and therapeutics, 63(1), 1998, pp. 26-38
NOVEL DIALYSIS NEEDLES - ARE THEY WORTH THE HIGHER PRICETAG
Authors: PFISTER M SCHADELI F BUHLER M FREY FJ UEHLINGER DE
Citation: M. Pfister et al., NOVEL DIALYSIS NEEDLES - ARE THEY WORTH THE HIGHER PRICETAG, Journal of the American Society of Nephrology, 8, 1997, pp. 793-793
CLINICAL OUTCOME RELATIVE TO THE DOSE OF DIALYSIS IS NOT WHAT YOU THINK - THE FALLACY OF THE MEAN
Authors: GOTCH FA LEVIN NW PORT FK WOLFE RA UEHLINGER DE
Citation: Fa. Gotch et al., CLINICAL OUTCOME RELATIVE TO THE DOSE OF DIALYSIS IS NOT WHAT YOU THINK - THE FALLACY OF THE MEAN, American journal of kidney diseases, 30(1), 1997, pp. 1-15
CYCLOSPORINE-A PHARMACOKINETICS - COMPARISON BETWEEN THE STANDARD ANDTHE NEW MICROEMULSION FORMULA USING A POPULATION-BASED APPROACH
Authors: SCHAEDELI F FREY FJ MARTI HP UEHLINGER DE
Citation: F. Schaedeli et al., CYCLOSPORINE-A PHARMACOKINETICS - COMPARISON BETWEEN THE STANDARD ANDTHE NEW MICROEMULSION FORMULA USING A POPULATION-BASED APPROACH, Kidney international, 52(5), 1997, pp. 1428-1428
PROTEIN-INTAKE AND DIALYSIS DOSE - RESPONSE
Authors: UEHLINGER DE
Citation: De. Uehlinger, PROTEIN-INTAKE AND DIALYSIS DOSE - RESPONSE, Journal of the American Society of Nephrology, 7(7), 1996, pp. 1088-1088
ACUTE CYCLOSPORINE-INDUCED NEPHROTOXICITY IN RENAL-TRANSPLANT RECIPIENTS - THE ROLE OF THE TRANSPLANTED KIDNEY
Authors: WISSMANN C FREY FJ FERRARI P UEHLINGER DE
Citation: C. Wissmann et al., ACUTE CYCLOSPORINE-INDUCED NEPHROTOXICITY IN RENAL-TRANSPLANT RECIPIENTS - THE ROLE OF THE TRANSPLANTED KIDNEY, Journal of the American Society of Nephrology, 7(12), 1996, pp. 2677-2681
ANOTHER LOOK AT THE RELATIONSHIP BETWEEN PROTEIN-INTAKE AND DIALYSIS DOSE
Authors: UEHLINGER DE
Citation: De. Uehlinger, ANOTHER LOOK AT THE RELATIONSHIP BETWEEN PROTEIN-INTAKE AND DIALYSIS DOSE, Journal of the American Society of Nephrology, 7(1), 1996, pp. 166-168
DOES CONTINUOUS RENAL REPLACEMENT THERAPY FAVORABLY INFLUENCE THE OUTCOME OF THE PATIENTS
Authors: JAKOB SM FREY FJ UEHLINGER DE
Citation: Sm. Jakob et al., DOES CONTINUOUS RENAL REPLACEMENT THERAPY FAVORABLY INFLUENCE THE OUTCOME OF THE PATIENTS, Nephrology, dialysis, transplantation, 11(7), 1996, pp. 1250-1255
HEMODIALYSIS ACTIVATES PHOSPHOLIPASE A(2) ENZYME
Authors: VISHWANATH BS FUX CA UEHLINGER DE FREY BM FRANSON RC FREY FJ
Citation: Bs. Vishwanath et al., HEMODIALYSIS ACTIVATES PHOSPHOLIPASE A(2) ENZYME, Nephrology, dialysis, transplantation, 11(1), 1996, pp. 109-116
THE SOLUTE REMOVAL INDEX - A NEW NAME FOR AN OLD CONCEPT
Authors: UEHLINGER DE
Citation: De. Uehlinger, THE SOLUTE REMOVAL INDEX - A NEW NAME FOR AN OLD CONCEPT, Peritoneal dialysis international, 16(1), 1996, pp. 94-95
THE SOLUTE REMOVAL INDEX (SRI) - A FLAWED MARKER OF DIALYSIS ADEQUACY
Authors: UEHLINGER DE
Citation: De. Uehlinger, THE SOLUTE REMOVAL INDEX (SRI) - A FLAWED MARKER OF DIALYSIS ADEQUACY, Kidney international, 50(4), 1996, pp. 1431-1431
LACK OF EVIDENCE FOR BETTER SURVIVAL RATES OF PATIENTS TREATED WITH CONTINUOUS THAN WITH INTERMITTENT HEMODIALYSIS PROCEDURES
Authors: JAKOB SM FREY FJ UEHLINGER DE
Citation: Sm. Jakob et al., LACK OF EVIDENCE FOR BETTER SURVIVAL RATES OF PATIENTS TREATED WITH CONTINUOUS THAN WITH INTERMITTENT HEMODIALYSIS PROCEDURES, Kidney international, 50(4), 1996, pp. 1432-1433
PHARMACOKINETICS OF FLEROXACIN AFTER MULTIPLE ORAL DOSING IN PATIENTSRECEIVING REGULAR HEMODIALYSIS
Authors: UEHLINGER DE SCHAEDELI F KINZIG M SORGEL F FREY FJ
Citation: De. Uehlinger et al., PHARMACOKINETICS OF FLEROXACIN AFTER MULTIPLE ORAL DOSING IN PATIENTSRECEIVING REGULAR HEMODIALYSIS, Antimicrobial agents and chemotherapy, 40(8), 1996, pp. 1903-1909
LACK OF EVIDENCE FOR BETTER SURVIVAL RATES OF PATIENTS TREATED WITH CONTINUOUS THAN WITH INTERMITTENT HEMODIALYSIS PROCEDURES
Authors: JAKOB SM FREY FJ UEHLINGER DE
Citation: Sm. Jakob et al., LACK OF EVIDENCE FOR BETTER SURVIVAL RATES OF PATIENTS TREATED WITH CONTINUOUS THAN WITH INTERMITTENT HEMODIALYSIS PROCEDURES, Journal of the American Society of Nephrology, 6(3), 1995, pp. 538-538
ANOTHER LOOK AT THE RELATIONSHIP BETWEEN PROTEIN-INTAKE AND DIALYSIS DOSE
Authors: UEHLINGER DE
Citation: De. Uehlinger, ANOTHER LOOK AT THE RELATIONSHIP BETWEEN PROTEIN-INTAKE AND DIALYSIS DOSE, Journal of the American Society of Nephrology, 6(3), 1995, pp. 616-616
PHARMACOKINETICS OF FLEROXACIN AFTER MULTIPLE DOSING IN PATIENTS ON CHRONIC-HEMODIALYSIS
Authors: UEHLINGER DE SCHAEDELI F WEIDEKAMM E FREY FJ
Citation: De. Uehlinger et al., PHARMACOKINETICS OF FLEROXACIN AFTER MULTIPLE DOSING IN PATIENTS ON CHRONIC-HEMODIALYSIS, Kidney international, 48(1), 1995, pp. 297-297
MORTALITY AND HYPOTENSIVE EPISODES WITH SHORT-TIME HIGH-FLUX DIALYSIS(HFD)
Authors: UEHLINGER DE KEEN M GOTCH FA
Citation: De. Uehlinger et al., MORTALITY AND HYPOTENSIVE EPISODES WITH SHORT-TIME HIGH-FLUX DIALYSIS(HFD), Kidney international, 45(6), 1994, pp. 1790-1790
EPSTEIN-BARR-VIRUS INFECTION IN HIV-POSITIVE PATIENTS
Authors: TELENTI A UEHLINGER DE MARCHESI F GERMANN D MALINVERNI R MATTER L
Citation: A. Telenti et al., EPSTEIN-BARR-VIRUS INFECTION IN HIV-POSITIVE PATIENTS, European journal of clinical microbiology & infectious diseases, 12(8), 1993, pp. 601-609
Risultati: 1-18 |